Remarkably, the addition of the human recombinant AGR2-ΔKTEL (40 ng/ml) to the extracellular medium of AGR2-depleted organoids was still able to restore the formation of tumor organoids (Figure 6D). This evidence concerns the gene AGR2 and neoplasm.